Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience.
第一作者:
M V,Bluthgen
第一单位:
Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
作者:
医学主题词
投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);复发(Recurrence);再治疗(Retreatment);回顾性研究(Retrospective Studies);胸腺肿瘤(Thymus Neoplasms)
DOI
10.1016/j.lungcan.2016.06.020
PMID
27565923
发布时间
2018-01-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



